World's Best Scientists 2026 revealed!
Jeffrey L. Probstfield

Jeffrey L. Probstfield

D-Index & Metrics

Medicine

D-Index
94
Citations
91658
World Ranking
10224
National Ranking
5257

Jeffrey L. Probstfield publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Jeffrey L. Probstfield sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 283 publications — 13th percentile

13% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Jeffrey L. Probstfield D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Jeffrey L. Probstfield sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 94 D-Index — 49th percentile

49% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Jeffrey L. Probstfield is affiliated with the University of Washington in the United States. Their research spans the broad field of Medicine, with a primary focus on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism, Emergency Medicine, Surgery, and Molecular Biology.

The scientist has contributed extensively to topics such as Diabetes Treatment and Management, Atrial Fibrillation Management and Outcomes, Antiplatelet Therapy and Cardiovascular Diseases, Venous Thromboembolism Diagnosis and Management, Metabolism, Diabetes, and Cancer, Cardiac Arrest and Resuscitation, and Cardiovascular Function and Risk Factors.

Jeffrey L. Probstfield's frequent publication venues include:

  • Resuscitation
  • Circulation
  • The Lancet Diabetes & Endocrinology
  • American Heart Journal
  • European Journal of Heart Failure

The scientist's recent papers include:

  • Effect of dulaglutide on cognitive impairment in type 2 diabetes: an exploratory analysis of the REWIND trial, 2020, The Lancet Neurology
  • Effect of statin therapy on muscle symptoms: an individual participant data meta-analysis of large-scale, randomised, double-blind trials, 2022, The Lancet
  • Role of Combination Antiplatelet and Anticoagulation Therapy in Diabetes Mellitus and Cardiovascular Disease, 2020, Circulation
  • The effect of dulaglutide on stroke: an exploratory analysis of the REWIND trial, 2020, The Lancet Diabetes & Endocrinology
  • Rivaroxaban Plus Aspirin Versus Aspirin Alone in Patients With Prior Percutaneous Coronary Intervention (COMPASS-PCI), 2020, Circulation

Frequent co-authors of this scientist include Hertzel C. Gerstein, Kelley R. Branch, Gilles R. Dagenais, Fernando Laņas, and Nana Pogosova. These collaborations indicate active partnerships in related cardiovascular and metabolic research areas.

Best Publications

  • Effects of intensive glucose lowering in type 2 diabetes

    Hertzel C Gerstein;Michael E Miller;Robert P Byington

  • Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT)

    Curt D. Furberg;Jackson T. Wright;Barry R Davis;Jeffrey A. Cutler

  • High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies.

    D. J. Gordon;J. L. Probstfield;R. J. Garrison;Jim Neaton

  • Effects of intensive blood-pressure control in type 2 diabetes mellitus.

    C. Cushman;Gregory W. Evans;Robert P. Byington;Jeffrey A. Cutler

  • Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy

    Patrice Desvignes-Nickens;Kent Koprowicz;Ruth McBride;Koon Teo

  • Effects of combination lipid therapy in type 2 diabetes mellitus.

    Henry N. Ginsberg;Laura C. Lovato;Lawrence A. Leiter;Peter Linz

  • Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT).

    Scott M. Lippman;Eric A. Klein;Eric A. Klein;Phyllis J. Goodman;M. Scott Lucia

  • Spironolactone for Heart Failure with Preserved Ejection Fraction

    Bertram Pitt;Marc A. Pfeffer;Susan F. Assmann;Robin Boineau

  • Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome

    Marc A. Pfeffer;Brian L. Claggett;Rafael Diaz;Kenneth Dickstein

  • Homocysteine Lowering with Folic Acid and B Vitamins in Vascular Disease

    Eva Lonn;Salim Yusuf;J. Arnold;Janice Pogue

  • Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease

    John W. Eikelboom;Stuart J. Connolly;Jackie Bosch;Gilles R. Dagenais

  • Design of the Women's Health Initiative clinical trial and observational study

    G. Anderson;S. Cummings;L. S. Freedman;C. Furberg

  • Basal insulin and cardiovascular and other outcomes in dysglycemia

    Origin Trial Investigators;Hertzel C Gerstein;Jackie Bosch;Gilles R Dagenais

  • Success and predictors of blood pressure control in diverse North American settings: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT).

    William C. Cushman;Charles E. Ford;Jeffrey A. Cutler;Karen L. Margolis

  • Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial.

    Eva Lonn;Jackie Bosch;Salim Yusuf;Patrick Sheridan

  • Comparison of candesartan, enalapril, and their combination in congestive heart failure: randomized evaluation of strategies for left ventricular dysfunction (RESOLVD) pilot study. The RESOLVD Pilot Study Investigators.

    R. S. McKelvie;S. Yusuf;D. Pericak;A. Avezum

  • Analysis and interpretation of treatment effects in subgroups of patients in randomized clinical trials.

    Salim Yusuf;Janet Wittes;Jeffrey Probstfield;Herman A. Tyroler

  • Erectile Dysfunction and Subsequent Cardiovascular Disease

    Ian M. Thompson;Catherine M. Tangen;Phyllis J. Goodman;Jeffrey L. Probstfield

  • Long-Term Effects of Intensive Glucose Lowering on Cardiovascular Outcomes

    Hertzel C. Gerstein;Michael E. Miller;Saul Genuth;Faramarz Ismail-Beigi

  • Lipids, lipoproteins, and apolipoproteins as risk markers of myocardial infarction in 52 countries (the INTERHEART study): a case-control study

    Matthew J McQueen;Steven Hawken;Xingyu Wang;Stephanie Ounpuu

Frequent Co-Authors

Salim Yusuf
Salim Yusuf McMaster University
Hertzel C. Gerstein
Hertzel C. Gerstein McMaster University
Rafael Diaz
Rafael Diaz University of Alberta
Barry R. Davis
Barry R. Davis The University of Texas Health Science Center at Houston
Jackie Bosch
Jackie Bosch McMaster University
Gilles R. Dagenais
Gilles R. Dagenais Université Laval
Aldo P. Maggioni
Aldo P. Maggioni Heart Care Foundation, ANMCO Research Center, Florence
Lars Rydén
Lars Rydén Karolinska Institute
William C. Cushman
William C. Cushman University of Tennessee Health Science Center
Alvaro Avezum
Alvaro Avezum Population Health Research Institute

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying medicine in the USA opens doors to a wide range of healthcare careers beyond traditional medical school. Many students begin their journey by pursuing nursing. For prospective students who want a direct route into nursing, some may benefit from a nursing school that doesn't require teas or HESI exams, offering an alternative path to enter the field quickly.

If you’re interested in the administrative side of healthcare, online health administration programs can prepare you for leadership roles in hospitals, clinics, and other healthcare organizations. These flexible degrees are ideal for those looking to balance studies with existing commitments.

For nurses seeking career advancement, bridge programs like adn to np provide a streamlined path to becoming a Nurse Practitioner, expanding both clinical skills and job opportunities.

Additionally, students passionate about preventative health and nutrition can explore online nutrition degree programs to build expertise in dietetics and wellness.

Each of these educational pathways can complement or provide alternatives to a traditional medicine degree, broadening your options within the healthcare industry.

Best Scientists Citing Jeffrey L. Probstfield

Trending Scientists